94
U. Eiamprasert et al. / Journal of Photochemistry and Photobiology A: Chemistry 352 (2018) 86–97
stirring for 2 h. The crude product 4c was used in the further step
without chromatographic purification.
16H), 6.91 (dd, J = 8.6, 2.7 Hz, 4H), 3.90 (t, J = 7.3 Hz, 4H), 2.34 (s, 6H),
1.88–1.80 (m, 4H), 1.48–1.43 (m, 4H), 1.34–1.31 (m, 8H), 0.89
(t, J = 6.9 Hz, 6H). 13C NMR (100 MHz, CDCl3):
d 190.15, 150.62,
4.2.5. tris(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)
amine (4d)
147.32, 146.74, 144.97, 142.12, 136.37, 134.76, 133.37, 133.24, 131.07,
130.30, 130.20, 128.53, 127.41, 127.23, 125.73, 125.49, 125.36,
124.63, 124.11, 123.99, 123.59, 116.19, 114.77, 48.22, 31.52, 26.82,
Following the procedure described for 4a, a mixture of 3d
(482 mg, 1.00 mmol), bis(pinacolato)diboron (838 mg, 3.30 mmol),
Pd2(dba)3 (13.7 mg, 0.015 mmol), Xphos (29.2 mg, 0.061 mmol) and
KOAc (883 mg, 9.00 mmol) was heated at 100 ꢁC in anhydrous 1,4-
dioxane (12 mL) for 16 h. The crude product 4d was used in the
further step without chromatographic purification.
26.66, 22.72, 21.03, 14.13. IR:
1460, 1318, 1242, 1194, 809 cmꢀ1. HRMS (ESI) m/z: calcd. for
76H70N4O2S2Na [M + Na]+, 1157.4838; found, 1157.4834.
n
2917, 1685 (C¼O), 1599, 1578, 1490,
C
4.2.9. 7,70,700-(nitrilotris(benzene-4,1-diyl))tris(10-hexyl-10H-
phenothiazine-3-carbaldehyde) (5d)
4.2.6. 7-(4-(di-p-tolylamino)phenyl)-10-hexyl-10H-phenothiazine-3-
carbaldehyde (5a)
Following the procedure described for 5a, a mixture of 4d,
Pd2(dba)3 (13.7 mg, 0.015 mmol), Xphos (29 mg, 0.06 mmol), K3PO4
(1.06 g, 5.00 mmol), 2 (1.21 mg, 3.10 mmol), 1,4-dioxane (10 mL)
and water (1 mL) was heated to 100 ꢁC under argon atmosphere.
The crude product was purified by column chromatography
A solution of 2 (390 mg, 1.0 mmol) in dried toluene (2.5 mL) was
added to a mixture of the 4a, Pd2(dba)3 (9.2 mg, 0.01 mmol), Xphos
(19.1 mg, 0.04 mmol), K3PO4 (530 mg, 2.5 mmol) under argon
atmosphere. The mixture was stirred at room temperature for
5 min prior to addition of pure water (0.5 mL). The reaction was
heated to 100 ꢁC for 4 h. After completion of the reaction, the
mixture was diluted with EtOAc. The organic phase was washed
with brine and dried over anhydrous Na2SO4. The crude product
was purified by EtOAc/hexanes (5:95 v/v) to afford 0.36 g (65%) of a
(CH2Cl2) to provide 0.78 g (67%) of
a bright orange solid.
1H NMR (400 MHz, CDCl3):
d
9.78 (s, 3H), 7.63 (dd, J = 8.4, 1.9 Hz,
3H), 7.58 (d, J = 1.9 Hz, 3H), 7.43 (d, J = 8.7 Hz, 6H), 7.36 (dd, J = 8.5,
2.1 Hz, 3H), 7.31 (d, J = 2.1 Hz, 3H), 7.17 (d, J = 8.7 Hz, 6H), 6.91ꢀ6.88
(m, 6H), 3.89 (t, J = 7.2 Hz, 6H), 1.87ꢀ1.79 (m, 6H), 1.47ꢀ1.42
(m, 6H), 1.33ꢀ1.31 (m, 12H), 0.88 (t, J = 7.1 Hz, 9H). 13C NMR
bright orange solid. 1H NMR (400 MHz, CDCl3):
d
9.79 (s, 1H), 7.65
(100 MHz, CDCl3): d 190.09, 150.53, 146.76, 142.29, 136.15, 134.16,
(dd, J = 8.4,1.9 Hz,1H), 7.59 (d, J = 1.9 Hz,1H), 7.36–7.32 (m, 3H), 7.29
(d, J = 2.1 Hz, 1H), 7.09–7.01 (m, 10H), 6.89 (d, J = 8.5 Hz, 2H), 3.89
(t, J = 7.3 Hz, 2H), 2.32 (s, 6H), 1.87–1.80 (m, 2H), 1.59–1.42 (m, 2H),
1.34–1.31 (m, 4H), 0.88 (t, J = 8.0 Hz, 3H). 13C NMR (100 MHz,
131.10, 130.33,128.46, 127.41, 125.79, 125.53,124.59,124.55, 124.18,
116.20, 114.79, 48.21, 31.51, 26.81, 26.64, 22.70, 14.11. IR: 2921,
n
1681 (C
O), 1598, 1578, 1462, 1241, 1193, 804 cmꢀ1. HRMS (ESI) m/
¼
z: calcd. for C75H72N4O3S3 [M]+, 1172.4767; found 1172.4760.
CDCl3):
d 190.16, 150.66, 147.73, 145.27, 142.01, 136.50, 132.82,
132.54,131.06,130.28,130.05,128.56,127.10,125.67,125.45,124.85,
124.66, 124.07, 122.73, 116.17, 114.76, 48.22, 31.53, 26.83, 26.67,
4.2.10. (E)-2-cyano-3-(7-(4-(di-p-tolylamino)phenyl)-10-hexyl-10H-
phenothiazin-3-yl)acrylic acid (TP)
22.72, 20.97, 14.12. IR:
n
2917, 1682 (C
¼
O), 1600, 1578, 1505, 1463,
A mixture of compound 5a (100 mg, 0.17 mmol), cyanoacetic
acid (73 mg, 0.86 mmol) and NH4OAc (66 mg, 0.86 mmol) under
argon atmosphere was heated to 100 ꢁC in a degassed glacial acetic
acid (8 mL) for 5 h. After cooled down to room temperature, excess
water was poured into the reaction flask and stirred for additional
2 h. The precipitate was subjected to vacuum filtration and the
solid was dried by heating at 50 ꢁC under reduced pressure. 106 mg
(95%) of a brown solid was obtained. 1H NMR (400 MHz, (CD3)2CO):
1319, 1241, 1193, 810 cmꢀ1. HRMS (ESI) m/z: calcd. for C39H39N2OS
[M + H]+, 583.2783; found, 583.2788.
4.2.7. 7,7'-((p-tolylazanediyl)bis(4,1-phenylene))bis(10-hexyl-10H-
phenothiazine-3-carbaldehyde) (5b)
Following the procedure described for 5a, a mixture of 4b,
Pd2(dba)3 (18 mg, 0.02 mmol), Xphos (38 mg, 0.08 mmol), K3PO4
(1.1 g, 2.5 mmol) and 2 (780 mg, 2.0 mmol) was heated to 100 ꢁC
under argon atmosphere in toluene (5 mL) and water (1 mL). The
crude product was purified by column chromatography (80–90%
CH2Cl2/hexanes) to afford 0.35 g (40%) of a bright orange solid. 1H
d
8.13 (s, 1H), 7.94 (dd, J = 8.7, 2.1 Hz, 1H), 7.86 (d, J = 2.1 Hz, 1H), 7.50
(d, J = 8.7 Hz, 2H), 7.46 (dd, J = 8.5, 2.2 Hz,1H), 7.37 (d, J = 2.1 Hz,1H),
7.16ꢀ7.10 (m, 6H), 7.00ꢀ6.96 (m, 6H), 4.03 (t, J = 7.2 Hz, 2H), 2.29 (s,
6H), 1.87ꢀ1.79 (m, 2H), 1.52ꢀ1.45 (m, 2H), 1.37ꢀ1.28 (m, 4H), 0.85
NMR (400 MHz, CDCl3):
d
9.78 (s, 2H), 7.63 (dd, J = 8.4, 1.9 Hz, 2H),
(t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, (CD3)2CO):
d 164.25, 153.61,
7.58 (d, J = 1.9 Hz, 2H), 7.39 (d, J = 8.6 Hz, 4H), 7.35 (dd, J = 8.5, 2.1 Hz,
2H), 7.30 (d, J = 2.1 Hz, 2H), 7.12–7.05 (m, 8H), 6.91–6.88 (m, 4H),
3.89 (t, J = 7.2 Hz, 4H), 2.34 (s, 3H), 1.87–1.79 (m, 4H), 1.49–1.42 (m,
4H), 1.34–1.31 (m, 8H), 0.88 (t, J = 6.9 Hz, 6H). 13C NMR (100 MHz,
150.09, 148.49, 146.04, 142.56, 136.86, 133.54, 133.05, 132.62,
130.82,130.49, 130.18, 127.74, 126.72,126.37, 125.53 (2 ꢂ C), 124.63,
124.22, 123.19, 117.42, 117.20, 116.20, 100.14, 48.35, 32.11, 27.30,
27.02, 23.27, 20.83, 14.27. IR:
n
2921, 2217 (CRN), 1694 (C O),
¼
CDCl3):
d
190.12, 150.59, 147.19, 144.86, 142.16, 136.31, 133.52,
1564, 1505, 1469, 1293, 1245 (CꢀꢀOH), 1198, 817 cmꢀ1. HRMS (ESI)
m/z: calcd. for C42H39N3O2S [M]+, 649.2763; found, 649.2765.
133.44,131.08,130.31,130.23,128.50,127.26,125.74,125.49,125.45,
124.62, 124.13, 123.76, 116.19, 114.77, 48.21, 31.52, 26.81, 26.65,
22.71, 21.03, 14.12. IR:
n
2919, 1681 (C
¼
O), 1599, 1578, 1460, 1241,
4.2.11. (2E,20E)-3,30-(((p-tolylazanediyl)bis(4,1-phenylene))bis(10-
hexyl-10H-phenothiazine-7,3-diyl))bis(2-cyanoacrylic acid) (TP2)
Following the procedure described for TP, a mixture of 5b
(100 mg, 0.11 mmol), cyanoacetic acid (97 mg, 1.1 mmol), NH4OAc
(88 mg, 1.1 mmol) in a degassed acetic acid (5 mL) was heated at
110 ꢁC for 2 h. 113 mg (98%) of a dark red powder was obtained. 1H
1193, 806 cmꢀ1. HRMS (ESI) m/z: calcd. for C57H55N3O2S2 [M]+,
877.3736; found, 877.3738.
4.2.8. 7,7'-((p-tolylazanediyl)bis(4,1-phenylene))bis(10-hexyl-10H-
phenothiazine-3-carbaldehyde) (5c)
Following the procedure described for 5a, a mixture of 4c,
Pd2(dba)3 (9.2 mg, 0.01 mmol), Xphos (19 mg, 0.04 mmol), K3PO4
(0.53 g, 2.5 mmol) and 2 (0.39 g, 1.0 mmol) under argon atmo-
sphere was heated to 100 ꢁC in toluene (2.5 mL) and water (0.5 mL).
The crude product was purified by chromatography (CH2Cl2/
hexanes, 4:1 v/v) to afford 0.18 g (32%) of a bright orange solid.
NMR (400 MHz, (CD3)2CO): d 8.16 (s, 2H), 7.98 (dd, J = 8.7, 2.0 Hz,
2H), 7.89 (d, J = 2.0 Hz, 2H), 7.58 (d, J = 8.6 Hz, 4H), 7.50 (dd, J = 8.5,
2.0 Hz, 2H), 7.42 (d, J = 2.0 Hz, 2H), 7.20–7.15 (m, 6H), 7.11
(d, J = 8.6 Hz, 4H), 7.05 (d, J = 8.3 Hz, 2H), 4.06 (t, J = 7.1 Hz, 4H),
2.34 (s, 3H),1.91–1.83 (m, 4H),1.53–1.48 (m, 4H),1.38–1.30 (m, 8H),
0.88 (t, J = 7.0 Hz, 6H). 13C NMR (100 MHz, (CD3)2CO):
d 164.16,
1H NMR (400 MHz, CDCl3):
d
9.79 (s, 2H), 7.64 (dd, J = 8.4, 1.9 Hz,
153.60, 149.99, 147.91, 145.62, 142.59, 136.69, 134.23, 133.92,
132.55,131.03,130.24,127.91, 126.69,126.48,126.21,125.61,124.59,
124.37, 124.17, 117.37, 117.20, 116.15, 100.06, 48.41, 32.13, 27.30,
2H), 7.59 (d, J = 1.9 Hz, 2H), 7.45 (d, J = 8.6 Hz, 4H), 7.40 (d, J = 8.6 Hz,
4H), 7.35 (dd, J = 8.5, 2.1 Hz, 2H), 7.31 (d, J = 2.1 Hz, 2H), 7.14–7.09 (m,